老挝人民民主共和国假药与劣质抗生素流行率的随机调查
2012年在老挝南部五省通过神秘顾客法分层随机抽样147家零售点,用HPLC测定909份样本中9种抗生素含量。所有样本均含标示活性成分、未发现伪造;但19.6%(201/1025)的样本单位含量超出标示量90%–110%,18.3%(188/1025)不符合国际药典/美国药典含量规格;甲氧苄啶含量偏低样本比例最高。
要点
- 所有分析样本均含标示活性成分,未发现伪造证据。
- 19.6%(201/1025)的样本单位含量超出标示量90%–110%范围。
- 18.3%(188/1025)的样本不符合国际药典/美国药典含量规格。
核心结论
- 在耐药性全球威胁下,需更深入理解劣质抗生素的作用;劣质抗生素将降低疗效,影响公共卫生和细菌感染控制。
研究设计与样本
- 2012年采用神秘顾客法进行分层随机调查,在老挝人民民主共和国南部五省10个区抽样147家零售点。
- 对909份样本中9种活性药物成分(阿莫西林、氨苄西林、头孢曲松、环丙沙星、多西环素、氧氟沙星、磺胺甲噁唑、四环素和甲氧苄啶)采用HPLC测定含量。
主要发现
- 所有分析样本均含标示活性成分,未发现伪造证据。
- 除一份样本外,所有样本所测单位含标示量75%–125%的活性药物成分。
- 19.6%(201/1025)的样本单位含量超出标示量90%–110%范围。
- 18.3%(188/1025)的样本单位不符合国际药典/美国药典含量规格。
- 甲氧苄啶含量低于限值范围的样本比例最高为51.6%(64),其次为头孢曲松42.9%(3)和磺胺甲噁唑34.7%(43);多西环素、氧氟沙星和环丙沙星含量偏高的样本比例分别为43.7%(38)、14.7%(10)和11.8%(2)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: In 2012, a stratified random survey, using mystery shoppers, was conducted to investigate the availability and quality of antibiotics sold to patients in the private sector in five southern provinces of the Lao People's Democratic Republic (Laos). METHODS: A total of 147 outlets were sampled in 10 districts. The active pharmaceutical ingredient (API) content measurements for 909 samples, including nine APIs (amoxicillin, ampicillin, ceftriaxone, ciprofloxacin, doxycycline, ofloxacin, sulfamethoxazole, tetracycline and trimethoprim), were determined using HPLC. RESULTS: All the analysed samples contained the stated API and we found no evidence for falsification. All except one sample had all the units tested with %API values between 75% and 125% of the content stated on the label. However, we identified the presence of substandard antibiotics: 19.6% (201/1025) of samples had their units outside the 90%-110% content of the label claim and 18.3% (188/1025) of the samples had units outside the International Pharmacopoeia/United States Pharmacopoeia assay (percentage of label claim) specifications. Trimethoprim had a high number of samples [51.6% (64)] with units below the limit range, followed by ceftriaxone [42.9% (3)] and sulfamethoxazole [34.7% (43)]. Doxycycline, ofloxacin and ciprofloxacin had the highest number of samples with high API content: 43.7% (38), 14.7% (10) and 11.8% (2), respectively. Significant differences in %API were found between stated countries of manufacture and stated manufacturers. CONCLUSIONS: With the global threat of antimicrobial resistance on patient outcomes, greater understanding of the role of poor-quality antibiotics is needed. Substandard antibiotics will have reduced therapeutic efficacy, impacting public health and control of bacterial infections.
引用
- Tabernero P, Swamidoss I, Mayxay M, et al. A random survey of the prevalence of falsified and substandard antibiotics in the Lao PDR. J Antimicrob Chemother. 2022. PMID: 35137095. doi:10.1093/jac/dkab435
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。